Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 267

1.
2.
3.

Neuropsychologic predictors of competency in Alzheimer's disease using a rational reasons legal standard.

Marson DC, Cody HA, Ingram KK, Harrell LE.

Arch Neurol. 1995 Oct;52(10):955-9.

PMID:
7575222
4.

Assessing the competency of patients with Alzheimer's disease under different legal standards. A prototype instrument.

Marson DC, Ingram KK, Cody HA, Harrell LE.

Arch Neurol. 1995 Oct;52(10):949-54.

PMID:
7575221
5.

Consistency of physicians' legal standard and personal judgments of competency in patients with Alzheimer's disease.

Marson DC, Earnst KS, Jamil F, Bartolucci A, Harrell LE.

J Am Geriatr Soc. 2000 Aug;48(8):911-8.

PMID:
10968294
6.

Cognitive models that predict physician judgments of capacity to consent in mild Alzheimer's disease.

Marson DC, Hawkins L, McInturff B, Harrell LE.

J Am Geriatr Soc. 1997 Apr;45(4):458-64.

PMID:
9100715
7.

Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease.

Dymek MP, Atchison P, Harrell L, Marson DC.

Neurology. 2001 Jan 9;56(1):17-24.

PMID:
11148230
8.
9.

[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].

Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S.

Encephale. 2003 May-Jun;29(3 Pt 1):266-72. French.

PMID:
12876552
10.

Error behaviors associated with loss of competency in Alzheimer's disease.

Marson DC, Annis SM, McInturff B, Bartolucci A, Harrell LE.

Neurology. 1999 Dec 10;53(9):1983-92.

PMID:
10599769
11.

Capacity to consent to research participation in adults with malignant glioma.

Marson DC, Martin RC, Triebel KL, Nabors LB.

J Clin Oncol. 2010 Aug 20;28(24):3844-50. doi: 10.1200/JCO.2009.27.9091. Epub 2010 Jul 19.

PMID:
20644102
12.

Consistency of physician judgments of capacity to consent in mild Alzheimer's disease.

Marson DC, McInturff B, Hawkins L, Bartolucci A, Harrell LE.

J Am Geriatr Soc. 1997 Apr;45(4):453-7.

PMID:
9100714
13.

Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects.

Smith GE, Bohac DL, Waring SC, Kokmen E, Tangalos EG, Ivnik RJ, Petersen RC.

Neurology. 1998 Feb;50(2):355-62.

PMID:
9484353
14.

Cognitive test performance in detecting, staging, and tracking Alzheimer's disease.

Locascio JJ, Growdon JH, Corkin S.

Arch Neurol. 1995 Nov;52(11):1087-99.

PMID:
7487561
15.

[Awareness of deficits and anosognosia in Alzheimer's disease].

Antoine C, Antoine P, Guermonprez P, Frigard B.

Encephale. 2004 Nov-Dec;30(6):570-7. Review. French.

PMID:
15738860
17.

Age at onset and pattern of neuropsychological impairment in mild early-stage Alzheimer disease. A study of a community-based population.

Reid W, Broe G, Creasey H, Grayson D, McCusker E, Bennett H, Longley W, Sulway MR.

Arch Neurol. 1996 Oct;53(10):1056-61.

PMID:
8859068
18.

Utility of behavioral versus cognitive measures in differentiating between subtypes of frontotemporal lobar degeneration and Alzheimer's disease.

Heidler-Gary J, Gottesman R, Newhart M, Chang S, Ken L, Hillis AE.

Dement Geriatr Cogn Disord. 2007;23(3):184-93. Epub 2007 Jan 12.

PMID:
17220629
19.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. French.

PMID:
19081451
20.

Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.

Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkind M, Bell K, Stern Y, Devanand DP.

Arch Gen Psychiatry. 2006 Aug;63(8):916-24.

PMID:
16894068

Supplemental Content

Support Center